Artificial Bowel Sphincter Implantation for Faecal Incontinence in Asian Patients  by Chittawatanarat, Kaweesak et al.
134 ASIAN JOURNAL OF SURGERY VOL 33 • NO 3 • JULY 2010
© 2010 Elsevier. All rights reserved.
Original Article
Artificial Bowel Sphincter Implantation for 
Faecal Incontinence in Asian Patients
Kaweesak Chittawatanarat, Dean C. Koh, Aileen A. Seah, Wai-Kit Cheong, Charles B. Tsang
Division of Colorectal Surgery, Department of Surgery, National University Hospital, Singapore.
BACKGROUND: To evaluate the outcomes with the American Medical Systems artificial bowel sphincter
(ABS) implantation for the treatment of intractable faecal incontinence in an Asian population.
METHODS: Six Asian patients who underwent ABS implantation between March 2004 and December
2007 for the treatment of faecal incontinence were reviewed.
RESULTS: The ABS was successfully implanted in six patients [mean age 50 (20–73) years; 4 males]. The
most common causes of incontinence were congenital anomaly of the anus (imperforate anus status post
a pull-through procedure) and status-post ultralow anterior resection. Two patients required device
explantation due to postoperative infection. One eventually required a colostomy. After a mean follow-up
of 22 (4–36) months, four patients continued to have a functional artificial bowel sphincter. Faecal incon-
tinence severity scores improved from a mean of 13 (12–14) to 6 (0–9) postactivation. Anal manometry
showed an increase in mean resting pressures (19.2 ± 7.5 mmHg vs. postimplantation with cuff inflated
45.0 ± 12.0 mmHg). The comparative preoperative and postactivation faecal incontinence quality of life
scores showed improvement in all aspects.
CONCLUSIONS: Patients with successful ABS implantation benefited from improved outcomes in
function and quality of life. Infection was the most common cause of failure in our patients. [Asian J Surg
2010;33(3):134–42]
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Introduction
The artificial bowel sphincter (ABS) was adapted from the
artificial urinary sphincter (AMS800) which was introduced
in 1972 by American Medical Systems (Minnetonka, MN,
USA).1 In 1987, Christiansen and Lorentzen2 from
Denmark published the first account of its use for faecal
incontinence. Their patients had excellent results with no
complications after 3 months of follow-up. In 1996, the
ABS was then modified as the Acticon Neosphincter
device (American Medical Systems), specially designed for
faecal incontinence. Wong et al3 reported good functional
results with acceptable morbidity in their early experience.
This was seen as a feasible new option in the treatment of
severe faecal incontinence. Numerous studies have since
reported acceptable outcomes, good functional results,
effectiveness and safety of this new device.4−9 However,
most of these studies were performed in western coun-
tries. There are no known reports of results obtained from
Asian patients. The aim of this study was to report our
experience with the ABS implantation for the treatment
of faecal incontinence in this group of patients.
Patients and methods
Patients and study design
All patients presenting to the division of Colorectal
Surgery at the National University Hospital with severe
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intractable faecal incontinence, which did not respond 
to conservative treatment or whose defects of the anal
sphincter complex were deemed unsuitable for sphinc-
teroplasty, were considered for the procedure. Evaluation
with endoanal ultrasonography (EAUS), 8-channel water
perfusion manometry was then performed. Only patients
who were able to understand and manage the device were
selected for the procedure. These patients were educated
on the details of the device including its function and
mechanism. Informed consent was then obtained prior to
the implantation procedure. Following recovery from the
implantation procedure, all patients were again evaluated
using anal manometry. Two sets of readings were obtained:
one with the cuff inflated and the other with the cuff
deflated. The degree of continence was measured according
to the Wexner continence grading score system (CGS);10
which ranges from 0 (normal continence) to 20 (total
incontinence). Assessment of the quality of life (QOL) was
performed using the Fecal Incontinence Quality of Life
Instrument (FIQL).11 These were obtained preoperatively
and postoperatively. The postoperative FIQL scores were
obtained at least 3 months after successful implantation of
the device. The FIQL questionnaire comprises 29 items
assessing the four domains of quality of life: life style 
(10 items), coping/behaviour (9 items), depression/self-
perception (7 items) and embarrassment (3 items). Each
response to a specific item was assigned a value and scores
for each of the four individual FIQL scales were calculated
accordingly. We also used a summarized global score by
taking the mean of the four scores.11
Operative technique
After appropriate preoperative evaluation, all patients
were scheduled for elective implantation of the ABS
under general anesthesia. Informed consent was obtained
by the primary surgeon. Antibiotic prophylaxis using
intravenous cefazolin 1 g, metronidazole 500 mg and van-
comycin 1 g was administered 30 minutes prior to com-
mencement of the operation. Mechanical cleansing of the
colon was achieved by administering 2 L of poly-ethylene
glycol on the day before the procedure.
Patients were placed in a high lithotomy position. The
device used was the Acticon Neosphincter artificial 
bowel sphincter (American Medical Systems, Minneapolis,
Minnesota, USA) comprising three components: the
occlusive cuff, the pressure regulating balloon and the
control pump.
An anterior transverse curvilinear incision was made
around the anus to obtain access to the extra-sphincteric
space. The AMS cuff sizer was then used to determine the
required cuff length. The length of the anal canal was
used to approximate the width of the cuff required. The
appropriately sized cuff was then tested externally and then
soaked in a gentamicin solution prior to placement around
the anal sphincter complex, making sure that the fit was
snug and not overly constrictive. The pressure-regulating
balloon was placed in the prevesical space of Retzius via a
transverse suprapubic incision. The cuff was filled with
radio-opaque solution (Omnipaque; GE Healthcare Canada
Inc., Ontario, Canada) and the connecting tubes were
clamped. The reservoir balloon was then pressurized by
filling the balloon with 55 mL radio-opaque solution and
clamping inflow and outflow tubes. All the appropriate
tubes were connected and the fluid was allowed to equili-
brate between the cuff and the balloon. Adequate anal canal
compression was assessed digitally by the surgeon. The con-
trol pump was placed in the labia majora in women and the
scrotum in men. The connecting tube was tunneled sub-
cutaneously from the suprapubic incision. We made sure
that the activation button was easily palpable when sited in
the scrotum or the labia majora. Radiological confirmation
of the positions of all the components was obtained intra-
operatively. All wounds were irrigated with povidone iodine
and gentamicin solution (about 1 mg/dL concentration)
before closure. Oral antibiotics (ciprofloxacin and metron-
idazole) were continued for 24 hours postoperatively.
All patients were reviewed in the clinic regularly for a
duration of 2 months before the device was activated. This
was to ensure that there was no evidence of postoperative
infection. Figures 1 and 2 showed the final position of the
ABS in males and females.
Results
The median duration of incontinence was 2.5 years (range:
1–20 years). The aetiology of incontinence was postsurgi-
cal in four patients (two after posterior sagittal anorecto-
plasty, two after ultra low anterior resection), trauma in
one and peripheral neuropathy in one (Table 1). Two
patients had prior medical treatment and biofeedback
and another two underwent phase I sacral nerve modula-
tion. All had failed conservative treatment.
The size of the cuff was determined by the surgeon,
based on the assessment of the length of the anal canal.
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All 6 patients were implanted with the narrow-width cuff
(2 cm). The lengths of the cuffs used were 9 cm in two
patients, 10 cm in three patients and 11 cm in one patient.
The mean operative time was 161.7 minutes (range: 105–260
minutes; Table 1).
The median follow-up was 27 months (range: 0.25–52
months). Early postoperative infection of the perineal
wound occurred in two patients. One patient developed a
perineal wound dehiscence with exposure of the perianal
cuff and faecal contamination of the wound within the
first week. The cause of this was attributed to the inces-
sant scratching of the healing wound by the patient, who
was educationally subnormal and was unable to follow
the specific postoperative instructions. This necessitated
the eventual explantation of the device. The other
patient’s perineal wound dehisced two weeks following
Figure 2. Position after implantation in female.
Table 1. Demographic and general data of patients
Patient Race Age (yr) Gender
Cause of 
Preoperative Size of 
Follow-up Operative
incontinence cuff used 
incontinence
treatment (cm)
(mo) time (min)
1 Malay 64 Female Post ultra-low Ileostomy 11 0.25* 125
anterior resection
2 Indian 67 Female Neuropathy Medical treatment 9 3 195
3 Chinese 54 Male Penetrating Colostomy 10 5 175
anorectal 
trauma
4 Chinese 73 Male Post ultra-low Ileostomy 10 40 260
anterior resection
5 Chinese 22 Male Congenital Medical treatment 9 25 110
(imperforate anus
status-post pull 
through)
6 Indian 22 Male Congenital Medical treatment 10 25 105
(imperforate anus
status-post pull 
through)
*Patient developed wound dehiscence requiring explantation of the artificial bowel sphincter 1 week postoperatively.
Figure 1. Position after implantation in male.
the implantation procedure. This was treated successfully
with conservative measures using local wound irrigation
and oral antibiotics.
Late infection occurred in another patient at 14 weeks
after implantation. He was brought to the operating
room and the device had to be explanted (Table 2). This
patient was of a very thin body habitus, with little bulk in
his ischiorectal fossa. This was believed to be the cause of
the gradual erosion of the cuff through the skin and sub-
sequent infection. The overall explantation rate at the end
of study was 33%. Of the 2 patients who required explan-
tation, one underwent a colostomy, the other underwent
a graciloplasty.
Four patients were available for long term clinical eval-
uation. Two patients did not have any proximal diversion
prior to device implantation. Both had objective improve-
ment in continence to liquid and solid stools as evidenced
by a decrease of CGS from 12 and 14 to 9. Another patient
developed the subjective symptom of constipation follow-
ing activation of the ABS. This was subsequently found to
be a result of the improper use of the ABS. Diet modifica-
tion with re-education resulted in improved symptoms.
Patients who had a successful implantation of the device in
the long term showed improvements in the mean CGS
scores from 13 (range: 12–14) to 6.5 (range: 0–9; Figures 3
and 4, Tables 3 and 4).
We were unable to perform the FIQL and CGS com-
parisons for the two patients with stomas. For the remain-
ing patients, improvements in all scores were observed
except for the lifestyle domain.
Manometric results
Mean resting anal pressure was 19.2 ± 7.5 mmHg before
and 21.1 ± 5.5 mmHg (cuff deflated) after ABS implan-
tation. The preoperative squeeze pressure was 38.2 ±
6.4 mmHg and the mean postoperative anal resting 
pressure with the device activated (cuff inflated) was
45.0 ± 12.0 mmHg. There was an improvement in the
mean resting pressures increasing from 19.2 ± 7.5 mmHg
(preoperative) to 45.0 ± 12.0 mmHg (postoperative). The
mean length of the high-pressure anal zone or anal length
increased from 3.0 ± 0.8 cm to 5.1 ± 0.7 cm (Table 5,
Figures 5 and 6).
Discussion
The ABS has been well described in the literature as a suit-
able treatment option for faecal incontinence. This paper
describes our experience specific to an Asian population.
The results corroborate most reports in demonstrating
the effectiveness of the ABS in treating intractable faecal
incontinence. There were technical differences when com-
pared to the reports from the west. Considering that most
of our patients were of a smaller physical habitus, the cuff
width used in all our patients was 2.0 cm (narrow cuff).
This was a difference we noted when comparing with
those in the western population,where more than 50 per-
cent of the patients were implanted with a 2.9 cm cuff
(wide cuff).12 In addition, the circumference of the used
cuff in the western population was larger than those in
our series. (16.7% in our series vs. 85.7% in the Altomare
study12 with cuff circumference greater than 10 cm).
These differences can be attributed to the distinctive anal
anatomical differences between the two groups. The most
serious complication of the implanted ABS in our
patients was infection and/or erosion. The risk of infec-
tion is naturally increased owing to the implantation of a
foreign object in the anorectal region.13 The incidence of
infection following ABS implantation has been reported
to be 4–40%.6 Both the perineal and abdominal surgical
site may be involved in early infection (before activation
of ABS) despite the routine administration of perioperative
antibiotics and strict aseptic intra-operative measures.
Following activation, most infections are caused by the
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Table 2. Morbidity
Patient Complication Time after surgery (wk) End result
1 Cuff erosion from digital self manipulation 1 Explantation
and fecal contamination to ABS
2 Cuff erosion and perianal abscess 14 Explantation
5 Wound dehiscence 2 Conservative treatment
ABS = artificial bowel sphincter.
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erosion of the device through the perineal wound necessi-
tating explantation.6 However, we observed that our patients
have comparably less ischiorectal fat which may poten-
tially increase the risk of cuff erosion. The overall rate of
infection in our series was 50%; three of the six patients—
two were severe and required the device to be explanted,
the other patient had minor infection with wound dehis-
cence and was successfully treated conservatively. The rate
of explantation ranged from 16.7% after a mean follow up
period of 10 months in the Vaizey et al study14 to 41.2%
after a mean follow-up period of 5 years.5 The definitive
explantation rate, which is described as the permanent
removal of the device3,15,16 was 33.3% in our series. The
recent Cochrane review has revealed evidence showing
that the ABS is superior to conservative treatment in
improving faecal incontinence. However it is associated
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Figure 3. Comparison of preoperative four domain and global of
Fecal Incontinence Quality of Life (FIQL) scores. Individual and
mean (SD) FIQL scores in the four domains recorded before and
after artificial bowel sphincter implantation for two patients.
(The other 2 patients only had postoperative scores as they had
stomas prior to implantation of the artificial bowel sphincter).
FU = follow-up.
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scores and anal incontinence (FIS) scores.4 This was com-
parable to that of our patients, where the FIQL scores
were superior in all classes except for class 1 (Table 3,
Figures 3–6). Table 614,16,18,19 summarizes the results 
of continence grading scale in previous studies. The
improvements in CGS scores between our preimplant and
postimplant patients were comparable to previous reports
in the Western population.
A major concern with this device is the risk of ensuing
obstructed defecation. In our series, only one elderly patient
complained of constipation and impaired evacuation
after implantation. Altomare et al12 reviewed 28 patients
and found that over half of the patients complained of
some degree of difficulty in defecating and one-third had to
depend on daily enemas. Similar findings were reported
by Lehur et al16 and by Devesa et al15 with obstructed
defecation found in 29% and 22% of patients respectively.
We found that the reason for this outcome in our patients
Table 3. Preoperative and postoperative quality of life according to Fecal Incontinence Quality of Life (FIQL) and severity inconti-
nence score according to Continence Grading Score
Patient preoperation Ostomy FIQL1 FIQL2 FIQL3 FIQL4 Global Severity
3 Colostomy NA NA NA NA NA NA
4 Ileostomy NA NA NA NA NA NA
5 No 4 3.2 3.4 1.7 3.1 14
6 No 2.5 1.5 1.7 1.0 1.7 12
Mean ± SD 3.25 ± 1.06 2.35 ± 1.20 2.55 ± 1.20 1.35 ± 0.49 2.38 ± 0.99 13 ± 1.4
Patient postoperation
3 4 3.2 4 4 3.8 4
4 4 4.0 4 4 4 0
5 3.6 3.3 3.7 3.0 4 9
6 1.9 2.1 1.7 1.6 1.8 9
Mean ± SD 3.38 ± 1.00 3.15 ± 0.79 3.35 ± 1.11 3.15 ± 1.14 3.26 ± 0.99 5.5 ± 4.4
NA = not available.
Table 4. Comparison between quality of life according to Fecal Incontinence Quality of Life (FIQL) and severity incontinence score
according to Continence Grading Score
Ostomy
Comparison between preoperation and postoperation scores
FIQL1 FIQL2 FIQL3 FIQL4 Global Severity
3 Colostomy NA NA NA NA NA NA
4 Ileostomy NA NA NA NA NA NA
5 No −0.4 0.1 0.3 1.3 0.9 −5
6 No −0.6 0.6 0 0.6 0.1 −3
NA = not available.
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Figure 4. Mean Continence Grading Scores preimplantation and
postimplantation.
with a high incidence of significant morbidity (OR 11.67;
95% CI 0.48–282.04).17 Lehur et al16 used the FIQL scores
to assess the quality of life in 16 implanted patients. They
demonstrated significant improvements of the FIQL
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was the inability to properly deflate the cuff. These symp-
toms improved after re-education on the proper usage of
the device. This aspect of postoperative care should not
be overlooked. Romano et al20 showed that regular train-
ing contributed significantly to overcoming this problem
in patients. Another possible cause of obstructed defeca-
tion is a cuff selection that is too wide or overly inflated,
thereby making it stiff. Altomare et al12 reported a greater
difficulty in defecation in patients when a 2.9-cm cuff
(standard) was implanted compared to a 2.0-cm cuff (nar-
row). This potentially explains the lower incidence of this
symptom in our series.
The baseline mean preoperative resting pressure was
comparable to other reports (19 mmHg in our series vs.
16–45 mmHg in other studies; Table 73,7,12,14,15,19–22).
Following implantation, their resting pressure when the
cuff was inflated rose appropriately (45 mmHg in our
series vs. 54–85 mmHg in other studies). With deflation,
their pressure subsequently decreased to a mean resting
pressure of 21 mmHg (range: 32–37 mmHg in previous
studies), allowing for defecation. Whilst most reports
showed no difference in the mean anal length or high
pressure zone, we found that this was increased in our
patients (from 3 cm to 5 cm). This can be attributed to the
predominantly male patients in our series.
We are aware of the inevitable limitations of this study.
Firstly, the small number of patients in our series prevents
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Figure 6. Changes in high pressure zone or anal length before
and after artificial anal sphincter implantation.
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Figure 5. Changes in anal pressure (mmHg) before and after
artificial anal sphincter implantation.
Table 6. Continence grading scale (CGS)14,16,18,19
Study
Continence grading scale mean (range)
Before implantation After implantation
Valzey et al14* 96.2 (70–108) 19.4 (0–61)
Lehur et al16* 106 (13)† 25 (25)†
O’Brien et al18‡ 19 (18–20) 3 (0–6)
Ortiz et al19‡ 18 (14–20) 4 (0–14)
Present series‡ 13 (12–14) 5.5 (0–9)
*American Medical System Incontinence Score; †mean (SD);
‡Cleveland Clinic Florida Scale.
Table 5. Manometric results
Preoperative Preoperative Postoperative  Postoperative resting Postoperative
resting pressure squeezing resting pressure pressure (Cuff Preoperative anal lengthPatient
(mmHg) pressure (mmHg) (Cuff deflated; inflated; mmHg) anal length (cm) (cm)
mmHg)
3 8.1 30.3 25.9 47.9 3 4.1
4 25 38.8 17.3 31.6 2.1 5.1
5 21.5 46 15.5 56 4 5.5
6 22.1 37.6 25.8 59.9 3 5.7
Mean ± SD 19.2 ± 7.5 38.2 ± 6.4 21.1 ± 5.5 45.0 ± 12.0 3.0 ± 0.8 5.1 ± 0.7
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us from making any statistically significant conclusions.
Secondly, the main outcome measurements after device
implantation which included CGS score and FIQL scores
were not performed at the same points in time before and
after implantation, which may result in a lead time bias.
Thirdly, the retrospective nature of this study implies that
the management protocols were varied for each surgeon.
Finally, the FIQL questionnaire which has been validated
in the western population may not be appropriate in an
Asian population due to the difference in life style and
social values. In addition, some of the questions may be
misinterpreted during translation into the various dialects.
Nevertheless, this study does demonstrate improvements
in functional outcomes, quality of life and manometric
results with an acceptable of incidence of morbidity and
is the first reported series confined specifically to an
Asian population.
Conclusions
The Acticon Neosphincter is a suitable option for the
treatment of intractable faecal incontinence in Asian
patients. Infection remains the major impediment to
good outcomes.
Acknowledgements
Funding for this procedure was made available through
the Health Services Development Programme, Ministry
of Health, Singapore from 2003 to 2007.
References
1. Belyaev O, Muller C, Uhl W. Neosphincter surgery for fecal incon-
tinence: a critical and unbiased review of the relevant literature.
Surg Today 2006;36:295–303.
2. Christiansen J, Lorentzen M. Implantation of artificial sphincter
for anal incontinence. Lancet 1987;2:244–5.
3. Wong WD, Jensen LL, Bartolo DC, et al. Artificial anal sphincter.
Dis Colon Rectum 1996;39:1345–51.
4. Lehur PA, Zerbib F, Neunlist M, et al. Comparison of quality of
life and anorectal function after artificial sphincter implantation.
Dis Colon Rectum 2002;45:508–13.
5. Michot F, Costaglioli B, Leroi AM, et al. Artificial anal sphinc-
ter in severe fecal incontinence: outcome of prospective experi-
ence with 37 patients in one institution. Ann Surg 2003;237:
52–6.
6. Mundy L, Merlin TL, Maddern GJ, et al. Systematic review of
safety and effectiveness of an artificial bowel sphincter for faecal
incontinence. Br J Surg 2004;91:665–72.
7. Savoye G, Leroi AM, Denis P, et al. Manometric assessment of an
artificial bowel sphincter. Br J Surg 2000;87:586–9.
8. Wong WD, Congliosi SM, Spencer MP, et al. The safety and effi-
cacy of the artificial bowel sphincter for fecal incontinence:
results from a multicenter cohort study. Dis Colon Rectum
2002;45:1139–53.
9. O’Brien PE, Dixon JB, Skinner S, et al. A prospective, randomized,
controlled clinical trial of placement of the artificial bowel
sphincter (Acticon Neosphincter) for the control of fecal inconti-
nence. Dis Colon Rectum 2004;47:1852–60.
10. Jorge JM, Wexner SD. Etiology and management of fecal incon-
tinence. Dis Colon Rectum 1993;36:77–97.
11. Rockwood TH, Church JM, Fleshman JW. Fecal incontinence
quality of life scale: quality of life instrument for patients with
fecal incontinence. Dis Colon Rectum 2000;43:9–17.
Table 7. Manometric results in published literature3,7,12,14,15,19–22
Preoperative Preoperative 
Cuff deflated Cuff inflated Preoperative Postoperative
Study resting pressure squeezing pressure
(mmHg) (mmHg) anal length (cm) anal length (cm)
(mmHg) (mmHg)
Wong et al3 16 NA NA 68 NA NA
Devesa et al15 32 61 NA 55 NA NA
Lahur et al21 41 72 NA NA 1.9 2.1
Altomare et al12 27 42 32 67 Not different Not different
Vaizey et al14 42* (54.7) NA NA 85* (110) NA NA
Savoye et al7 39* (51) NA 37* (48) 83* (108) NA NA
Romano et al20 NA NA 32 62 NA NA
Casal et al22 45 75 NA 81 2.7 2.8
Ortiz et al19 35 NA NA 54 NA NA
Present series 19 38 21 45 3 5
*Values converted from cmH2O to mmHg, values in parentheses expressed in mmH2O. NA = not available.
12. Altomare DF, Dodi G, La Torre F, et al. Multicentre retro-
spective analysis of the outcome of artificial anal sphincter
implantation for severe faecal incontinence. Br J Surg 2001;
88:1481–6.
13. Christiansen J. The artificial anal sphincter. Can J Gastroenterol
2000;14(Suppl D):152D–4D.
14. Vaizey CJ, Kamm MA, Gold DM, et al. Clinical, physiological,
and radiological study of a new purpose-designed artificial
bowel sphincter. Lancet 1998;352:105–9.
15. Devesa JM, Rey A, Hervas PL, et al. Artificial anal sphincter: 
complications and functional results of a large personal series.
Dis Colon Rectum 2002;45:1154–63.
16. Lehur PA, Roig JV, Duinslaeger M. Artificial anal sphincter:
prospective clinical and manometric evaluation. Dis Colon Rectum
2000;43:1100–6.
17. Brown S, Nelson R. Surgery for faecal incontinence in adults.
Cochrane Database Syst Rev 2007;2:CD001757.
18. O’Brien PE, Skinner S. Restoring control: the Acticon Neo-
sphincter artificial bowel sphincter in the treatment of anal
incontinence. Dis Colon Rectum 2000;43:1213–6.
19. Ortiz H, Armendariz P, DeMiguel M, et al. Complications and func-
tional outcome following artificial anal sphincter implantation.
Br J Surg 2002;89:877–81.
20. Romano G, La Torre F, Cutini G, et al. Total anorectal recon-
struction with an artificial bowel sphincter: report of five cases
with a minimum follow-up of 6 months. Colorectal Dis 2002;
4:339–44.
21. Lehur PA, Glemain P, Bruley des Varannes S, et al. Outcome of
patients with an implanted artificial anal sphincter for severe
faecal incontinence. A single institution report. Int J Colorectal
Dis 1998;13:88–92.
22. Casal E, San Ildefonso A, Carracedo R, et al. Artificial bowel
sphincter in severe anal incontinence. Colorectal Dis 2004;6:
180–4.
■ CHITTAWATANARAT et al ■
142 ASIAN JOURNAL OF SURGERY VOL 33 • NO 3 • JULY 2010
